Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Brivio

Showing results (61-70 of 321) with videos related to

Pageof 33
Sort By:
In Vivo (Athens, Greece)|March 27, 2003
Clinical and biological effects of interleukin-2 with or without a concomitant administration of granulocyte-macrophage colony-stimulating factor in metastatic cancer patientsP Lissoni, S Mengo, R Bucovec, et al.
Journal of Biological Regulators and Homeostatic Agents|April 7, 2004
A psychoncological study of lymphocyte subpopulations in relation to pleasure-related neurobiochemistry and sexual and spiritual profile to Rorschach's test in early or advanced cancer patientsG Messina, P Lissoni, E Bartolacelli, et al.
Journal of Biological Regulators and Homeostatic Agents|October 1, 1992
Immunological effects of a single evening subcutaneous injection of low-dose interleukin-2 in association with the pineal hormone melatonin in advanced cancer patientsP Lissoni, S Barni, A Ardizzoia, et al.
Oncology Reports|October 19, 1999
Pre-operative IL-2 immunoprophylaxis of cancer recurrence: long-term clinical results of a phase II study in radically operable colorectal cancerF Brivio, P Lissoni, L Fumagalli, et al.
Anticancer Research|August 19, 2007
Efficacy of IL-2 immunotherapy in metastatic renal cell carcinoma in relation to the psychic profile as evaluated using the Rorschach testG Messina, P Lissoni, E Bartolacelli, et al.
Journal of Biological Regulators and Homeostatic Agents|April 11, 2006
Cortisol response to an acute injection of IL-2 in healthy subjects and cancer patients: a first immunoneuroendocrine standardized clinical test to explore the interactions between immune and neuroendocrine systemsP Lissoni, G Messina, F Brivio, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 1997
Acute effects of pamidronate administration on serum levels of interleukin-6 in advanced solid tumour patients with bone metastases and their possible implications in the immunotherapy of cancer with interleukin-2P Lissoni, M Cazzaniga, S Barni, et al.
Journal of Biological Regulators and Homeostatic Agents|October 1, 1992
Inhibitory effect of interleukin-3 on interleukin-2-induced cortisol release in the immunotherapy of cancerP Lissoni, F Rovelli, G Tancini, et al.
The European Journal of Surgery = Acta Chirurgica|January 1, 1993
Effects of a preoperative course of interleukin-2 on surgical and immunobiological variables in patients with colorectal cancer: a phase 2 studyF Brivio, P Lissoni, S Barni, et al.
Tumori|June 30, 1994
Serum levels of insulin-like growth factor-I in operable breast cancer in relation to the main prognostic variables and their perioperative changes in relation to those of prolactinS Barni, P Lissoni, F Brivio, et al.
Pageof 33

Showing results (61-70 of 321) with videos related to

Sort By:
Pageof 33
In Vivo (Athens, Greece)|March 27, 2003
Clinical and biological effects of interleukin-2 with or without a concomitant administration of granulocyte-macrophage colony-stimulating factor in metastatic cancer patientsP Lissoni, S Mengo, R Bucovec, et al.
Journal of Biological Regulators and Homeostatic Agents|April 7, 2004
A psychoncological study of lymphocyte subpopulations in relation to pleasure-related neurobiochemistry and sexual and spiritual profile to Rorschach's test in early or advanced cancer patientsG Messina, P Lissoni, E Bartolacelli, et al.
Journal of Biological Regulators and Homeostatic Agents|October 1, 1992
Immunological effects of a single evening subcutaneous injection of low-dose interleukin-2 in association with the pineal hormone melatonin in advanced cancer patientsP Lissoni, S Barni, A Ardizzoia, et al.
Oncology Reports|October 19, 1999
Pre-operative IL-2 immunoprophylaxis of cancer recurrence: long-term clinical results of a phase II study in radically operable colorectal cancerF Brivio, P Lissoni, L Fumagalli, et al.
Anticancer Research|August 19, 2007
Efficacy of IL-2 immunotherapy in metastatic renal cell carcinoma in relation to the psychic profile as evaluated using the Rorschach testG Messina, P Lissoni, E Bartolacelli, et al.
Journal of Biological Regulators and Homeostatic Agents|April 11, 2006
Cortisol response to an acute injection of IL-2 in healthy subjects and cancer patients: a first immunoneuroendocrine standardized clinical test to explore the interactions between immune and neuroendocrine systemsP Lissoni, G Messina, F Brivio, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 1997
Acute effects of pamidronate administration on serum levels of interleukin-6 in advanced solid tumour patients with bone metastases and their possible implications in the immunotherapy of cancer with interleukin-2P Lissoni, M Cazzaniga, S Barni, et al.
Journal of Biological Regulators and Homeostatic Agents|October 1, 1992
Inhibitory effect of interleukin-3 on interleukin-2-induced cortisol release in the immunotherapy of cancerP Lissoni, F Rovelli, G Tancini, et al.
The European Journal of Surgery = Acta Chirurgica|January 1, 1993
Effects of a preoperative course of interleukin-2 on surgical and immunobiological variables in patients with colorectal cancer: a phase 2 studyF Brivio, P Lissoni, S Barni, et al.
Tumori|June 30, 1994
Serum levels of insulin-like growth factor-I in operable breast cancer in relation to the main prognostic variables and their perioperative changes in relation to those of prolactinS Barni, P Lissoni, F Brivio, et al.
Pageof 33